![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 2, 1241-1247, January 14, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





¶
From the
Departments of Medicine and Physiology, Cardiovascular Research Institute, University of California, San Francisco, California 94143-0521 and the
Department of Nephrology, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8519, Japan
Received for publication, June 23, 2004 , and in revised form, September 20, 2004.
| ABSTRACT |
|---|
|
|
|---|
2-macroglobulin (
2M), which targets to late endosomes. In pulse label-chase experiments, [Cl] was 19 mM just after internalization in
2M-labeled endosomes in primary cultures of hepatocytes from wild-type mice, increasing to 58 mM over 45 min, whereas pH decreased from 7.1 to 5.4. Endosomal acidification and [Cl] accumulation were significantly impaired in hepatocytes from ClC-3 knock-out mice, with [Cl] increasing from 16 to 43 mM and pH decreasing from 7.1 to 6.0. Acidification and Cl accumulation were blocked by bafilomycin. In Tf-labeled endosomes, [Cl] was 46 mM in wild-type versus 35 mM in ClC-3-deficient hepatocytes at 15 min after internalization, with corresponding pH of 6.1 versus 6.5. Approximately 4-fold increased Cl conductance was found in
2M-labeled endosomes isolated from hepatocytes of wild-type versus ClC-3 null mice. In contrast, Golgi acidification was not impaired in ClC-3-deficient hepatocytes. In transfected Chinese hamster ovary cells expressing ClC-3A, endosomal acidification and [Cl] accumulation were enhanced. [Cl] in
2M-labeled endosomes was 42 mM (control) versus 53 mM (ClC-3A) at 45 min, with corresponding pH 5.8 versus 5.2; [Cl] in Tf-labeled endosomes at 15 min was 37 mM (control) versus 49 mM (ClC-3A) with pH 6.3 versus 5.9. Our results provide direct evidence for involvement of ClC-3 in endosomal acidification by Cl shunting of the interior-positive membrane potential created by the vacuolar H+ pump. | INTRODUCTION |
|---|
|
|
|---|
It has been proposed without direct evidence that ClC-type Cl channels are responsible for some or all endosomal Cl conductance in many cell types, and hence they may be a major determinant of endosomal acidification. There is evidence for expression of at least five members of the ClC Cl channel family (ClCs 37) in intracellular vesicles, including endosomes (reviewed in Ref. 11). ClC-3 is localized in synaptic vesicles in neurons, where it is thought to provide an electric shunt for the proton pump (12). Studies in transfected cells suggest that a shorter ClC-3 isoform (ClC-3A) is localized in late endosomes and lysosomes, where it may regulate organellar pH (13, 14). The function of a Golgi-localized longer ClC-3 isoform (ClC-3B) is not known (14, 15). ClC-5 is localized primarily in early endosomes in renal proximal tubules, where it appears to be involved in receptor-mediated endocytosis though its function as an electrical shunt has not yet been shown (16). A recent study reported ClC-4 expression in endosomal membranes and a possible role in endosomal acidification and trafficking in epithelial cells (17). Human mutations and/or knock-out mouse studies have implicated the involvement of ClC-3 in hippocampal degeneration (12, 18), ClC-5 in renal stone formation in Dent's disease (19, 20), and ClC-7 in osteopetrosis and retinal degeneration (21). A variety of mechanisms have been proposed by which defective endosomal Cl conductance and acidification could produce these defects.
The purpose of this study was to define the role of ClC-3 Cl channels in endosomal acidification and Cl accumulation. The kinetics of endosomal pH and [Cl] were measured in intact cells using two models: primary cultures of hepatocytes from wild-type and ClC-3 knock-out mice, and Chinese hamster ovary (CHO)1 cells after transfection with control or ClC-3A-encoding cDNA. In addition, measurements were made in Golgi to examine organelle-specific effects in ClC function. Hepatocytes were chosen as a readily cultured cell type that natively expresses ClC-3 (22, 23). CHO cells were chosen as an easily transfected cell type that expresses little or no ClC-3 and in which endosomal acidification and Cl accumulation have been studied extensively (9, 2427). The methodology for measurement of endosomal [Cl] by ratio imaging fluorescence micros-copy was established and validated recently by the Verkman laboratory. Cells are imaged after pulse label-chase with fluorescent ligands (transferrin, Tf, or
2-macroglobulin,
2M) containing Cl-sensitive and -insensitive chromophores (9). We report here that ClC-3 deletion in mice remarkably impairs endosomal acidification and [Cl] accumulation in hepatocytes and that transfection of ClC-3A into CHO cells enhances endosomal acidification and [Cl] accumulation.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Construction of cDNA Encoding Mouse CLC-3mRNA was isolated from mouse kidney (Oligo Direct mRNA kit; Qiagen) and cDNA was reverse transcribed using oligo(dT) (SuperScript II preamplification kit; Invitrogen). PCR amplification was performed with the cDNA template and primers designed from the mouse ClC-3A sequence (GenBankTM accession number NM_007711 [GenBank] ). Primers were engineered with BglII and XbaI restriction sites: sense, 5'-GAAGATCTCAATGACAAATGG-AGGCAGCATTAATAGC-3'; antisense, 5'-GCTCTAGAGTTGAACATT-ATTGAAGCGGGGTC-3'. The PCR product was subcloned into plasmid pcDNA6/Myc-His (Invitrogen), which introduces a c-Myc tag at the NH2 terminus. The full-length insert was confirmed by sequence analysis.
CHO Cell Culture and TransfectionCHO-K1 cells (ATCC number CCL-61) were grown in Ham's F12K medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. Cells were cultured on 18-mm-diameter round coverslips at 37 °C in 95% air-5% CO2 and used just prior to confluence.
CHO-K1 cells were transfected with cDNA encoding ClC-3A in pcDNA6/Myc-His using Lipofectamine 2000TM (Invitrogen). Measurements of endosomal pH and [Cl] were done at 2448 h after transfection.
Fluorescent Ligands for Endosomal/Golgi [Cl] and pH MeasurementsFluorescently labeled Tf,
2M, and cholera toxin B-subunit (CTb) were synthesized as described previously (9). Dual chromophore Cl-sensing conjugates contained the Cl-sensitive green-fluorescing chromophore 10,10'-bis[3-carboxypropyl]-9,9'-biacridinium dinitrate (BAC) and the Cl-insensitive chromophore tetramethylrhodamine (TMR). Ligands were labeled with TMR and conjugated 1:1 with BAC-dextran using an N-succinimidyl-3-(2-pyridyldithio)propionate disulfide linker (BAC-dextran-Tf-TMR for Tf conjugates, BAC-dextran-
2M-TMR for
2M conjugates). Dual chromophore pH-sensing conjugates were prepared by covalent conjugation with the pH-sensitive green-fluorescing chromophore FITC or 6-carboxyfluorescein (CF) and the pH-insensitive chromophore TMR (FITC-Tf-TMR for Tf conjugates, FITC-
2M-TMR for
2M conjugates). Previous studies established the purity, intracellular stability, and Cl/pH-sensing characteristics of these fluorescent ligands (9).
Endosome Labeling and Kinetics of Endosomal [Cl] and pHCells were incubated in serum-free medium for 15 min at 37 °C before experiments. Labeling of cell surface receptors was done by incubation with Cl or pH sensors (300 nM for Tf, 100 nM for
2M) for 20 min in PBS (containing 1 mM CaCl2 and MgCl2) at 4 °C. Coverslips were then washed twice with ice-cold PBS containing 1% bovine serum albumin and transferred to a precooled perfusion chamber containing ice-cold perfusate. Sets of BAC and TMR images (for Cl) or FITC and TMR images (for pH) were acquired at specified times after rapid warming by perfusion at 37 °C. In some experiments, the perfusate contained bafilomycin A1 (200 nM).
Golgi Compartment pHCells were incubated in serum-free medium for 30 min at 37 °C, washed three times with ice-cold PBS, and incubated with the Golgi pH indicator (200 nM) for 30 min in PBS at 4 °C. Coverslips were washed three times with ice-cold PBS and maintained at 37 °C for 45 min for Golgi targeting. CF and TMR images were acquired for pH determination.
Fluorescence Microscopy and Data AnalysisCells were imaged using a Leitz upright epifluorescence microscope equipped with a Nipkow-wheel confocal attachment and 14-bit cooled charge-coupled device camera (24). Fluorescence was collected using a x100 oil immersion objective (Nikon plan-apo, numerical aperture 1.4) and appropriate filter sets for BAC (excitation 470 ± 5 nm, dichroic 505 nm, emission 535 ± 20 nm), TMR, and FITC. Image analysis for computation of endosomal/Golgi [Cl] and pH was done using custom software to compute area-integrated background-subtracted pixel intensities (9, 24).
ImmunofluorescenceImmunofluorescence staining was done on paraformaldehyde-fixed (4%, 30 min) cells with c-Myc (prepared according to Ref. 29) and ClC-3 primary antibodies (Alamone Labs) and goat anti-mouse Alexa 555-conjugated IgG (Molecular Probes) or sheep anti-rabbit Cy3-conjugated IgG (Sigma) secondary antibodies. For immunoblot analysis, c-Myc antibody and horseradish peroxidase-conjugated secondary anti-mouse IgG antibody (Amersham Biosciences) were used for detection by enhanced chemiluminescence (Amersham Biosciences). To study fluorescent probe localization, hepatocytes were labeled with Tf conjugated to Alexa Fluor 488 (Molecular Probes),
2M-FITC (prepared according to Ref. 9), or CTb-FITC (Sigma), chased at 37 °C, paraformaldehyde fixed, and immunostained using antibodies against EEA1 (early endosome-associated protein; BD Transduction Laboratories), Rab-7 (Santa Cruz Biotechnology), giantin (Covance), or GM130 (BD Transduction Laboratories). Secondary antibodies were Alexa 555-conjugated goat anti-mouse (Molecular Probes) or Cy3-conjugated sheep anti-rabbit IgG (Sigma). Golgi was also labeled with the fluorescent vital dye boron dipyrromethene difluoride TR-ceramide (5 µM ceramide-bovine serum albumin complex for 30 min at 37 °C; Molecular Probes) after CTb-FITC pulse-chase.
Functional Analysis of Cl Transport in EndosomesHepatocytes were freshly isolated as described above and washed three times in PBS. Cells were incubated with the
2M Cl indicator (100 nM) for 45 min in PBS at 37 °C, washed three times, and then homogenized in ice-cold low Cl buffer (120 mM KNO3, 20 mM NaNO3, 1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES, pH 7.4). Homogenates were centrifuged at 3,500 x g for 10 min at 4 °C to remove nuclei, mitochondria, and debris. The supernatant containing fluorescently labeled endosomes was preincubated in low Cl buffer in the absence or presence of valinomycin (10 µM) for at least 10 min at 37 °C. To drive Cl influx, an isosmolar high Cl buffer (120 mM KCl, 20 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES, pH 7.4) was added to the stirred vesicle suspension to give 60 mM final [Cl]. BAC fluorescence in the vesicle suspension was measured continuously using a Fluoromax-3 fluorimeter (excitation 470 ± 10 nm, emission 535 ± 10 nm).
| RESULTS |
|---|
|
|
|---|
2M (bottom) with markers of early (EEA) and late (Rab7) endosomes, respectively. Fig. 1C shows fluorescence micrographs of hepatocytes after labeling with BAC-dextran-
2M-TMR and BAC-dextran-Tf-TMR at low temperature, followed by chase for 15 min (Tf) or 45 min (
2M) at 37 °C. A typical endosomal pattern was seen in the control and ClC-3-deficient hepatocytes, as found for internalization of Tf and
2M in many cell types (2, 9, 27, 30, 31). A membrane pattern was observed just after labeling, with progressive maturation over time (not shown). Cellular fluorescence was reduced to near zero when up to 100-fold excess unlabeled Tf or
2M was included in the labeling solution, confirming a receptor-mediated internalization mechanism.
|
7.2, decreasing over 15 min to 6.1 in control and 6.5 in ClC-3-deficient hepatocytes (Fig. 2A, left). Endosomal [Cl] increased in parallel from an initial low value of 16 to 46 mM in control and 35 mM in ClC-3-deficient hepatocytes (Fig. 2A, right). As reported for CHO cells (9), the low [Cl] early after endocytosis is probably the consequence of a Donnan potential produced by surface negative charges that excludes Cl during endosome formation. Endosomal acidification and Cl accumulation were blocked by inclusion of the H+ pump inhibitor bafilomycin in the perfusate. Fig. 2B shows that pH in
2M-labeled endosomes at 45 min was reduced to 5.4 in control and 6.0 in ClC-3-deficient hepatocytes. Corresponding [Cl] was increased to 58 mM in control and 43 mM in ClC-3-deficient hepatocytes. As found for early/recycling Tf-labeled endosomes, acidification and Cl accumulation were bafilomycin-sensitive and significantly impaired in ClC-3 deficiency.
|
|
2M-TMR. The staining patterns of BAC-dextran-Tf-TMR and BAC-dextran-
2M-TMR were characteristic of the ligands in early and late endosomes, respectively, as also seen for FITC and TMR labeled with Tf and
2M (not shown).
|
1:1 molar ratio as deduced using the measured endosomal buffer capacity of 28 mM H+/pH unit (9); for example, the pH drop of 0.72 units at 15 min in control endosomes corresponds to 20 mM H+ entry, similar to the increase in Cl of 19 mM at 15 min. In
2M-labeled endosomes, ClC-3 expression produced significantly enhanced endosomal acidification (pH 5.8 ± 0.1 versus 5.2 ± 0.2) and Cl accumulation (42 ± 3 versus 53 ± 3 mM) (Fig. 5B).
|
2M as done in intact cell studies. After incubation at 37 °C for 45 min, cells were homogenized, centrifuged, and suspended in a low Cl, high K+ buffer containing the K+ ionophore valinomycin to make Cl influx (rather than counterion transport) rate-limiting. Cl influx was measured selectively in fluorescently labeled endosomes in the heterogeneous membrane suspension from the kinetics of decreasing BAC fluorescence in response to mixing of the membrane suspension with an isosmolar high Cl buffer.
Fig. 6A shows the kinetics of Cl influx measured in endosomes from wild-type and ClC-3-deficient hepatocytes. There was little decrease in fluorescence corresponding to Cl influx in the absence of valinomycin, indicating a conductive Cl entry mechanism. ClC-3 deletion remarkably reduced Cl influx as seen from the slower decrease in fluorescence signal. Fig. 6B summarizes average Cl influx rates shown as reciprocal exponential time constants fitted to the kinetics of BAC fluorescence. Cl influx was significantly reduced by
4-fold in endosomes of ClC-3-deficient hepatocytes, although significant residual influx remained. This result indicates that ClC-3 is the main Cl conductive mechanism in the labeled endosomes. The non-zero Cl conductance in endosomes from ClC-3-deficient hepatocytes accounts in part for their ability to acidify, albeit less well than hepatocytes from wild-type mice.
|
| DISCUSSION |
|---|
|
|
|---|
ClC-3 is expressed in brain, liver, and other tissues (22) and has been reported to localize in intracellular vesicles (12) and the plasma membrane (36, 37). The phenotype of ClC-3 knock-out mice includes blindness and hippocampal neurodegeneration (12, 18). Indirect measurements of ATP-induced acidification by acridine orange uptake/quenching showed reduced uptake in isolated synaptic vesicles of ClC-3 versus wild-type mice (12), and estimated pH in isolated liver vesicles from ClC-3 null mice in the presence of ATP was greater than that of vesicles from wild-type mice (18). However, other reports of ClC-3A and ClC-3B localization (13, 14) and possible function as a swelling-activated Cl channel (12, 3638) draw somewhat contradictory conclusions. Here, we have shown that ClC-3 functions as an intracellular ClC-type Cl channel that facilitates endosomal acidification and Cl accumulation in intact cells, providing a possible explanation for the phenotypic abnormalities in ClC-3 null mice. Our conclusion about the role of ClC-3 in endosomal acidification in liver does not necessarily apply to other organs/cell types where different endosomal ion channels may be expressed. For example, ClC-5 may be important in endosomal acidification and Cl conductance in kidney proximal tubule cells where impaired endocytosis has been demonstrated in ClC-5 null mice (19) and may provide a mechanism for Dent's disease in ClC-5 deficiency in humans.
The partial impairment of endosomal acidification in ClC-3-deficient hepatocytes suggests that some, but not all, ion movement accompanying active H+ entry involves ClC-3-mediated Cl entry. The results in Fig. 6 suggest that ClC-3 provides the principal route for conductance of Cl entry. It is difficult to quantify the fraction of ionic movement through ClC-3 versus other channel pathways because of the complex set of determinants of endosomal acidification as described in the Introduction. Endosomes from hepatocytes may express other types of Cl channels, such as ClC-4 and/or K+ channels, that may be up-regulated as a compensatory response to ClC-3 gene deletion in mice. Also, endosomes in intact cells may differ from those in suspension in that regulatory factors may be different and little endosome fusion occurs. Notwithstanding the difficulties in ascribing the exact fraction of total ionic movement accompanying H+ entry, our results here support the involvement of ClC-3 in endosomal acidification.
The CHO cell transfection studies showed that overexpression of ClC-3A in a cell type that does not normally express ClC-3 produced an enhancement in endosomal acidification and Cl accumulation. Therefore, endogenous endosomal ion conductance (rather than the H+ pump) must be a rate-limiting determinant of endosomal acidification. Thus, regulation of the expression and/or function of ClC-3 or other endosomal ion channels can influence acidification kinetics and steady-state pH. Because Cl entry produces an osmotic gradient leading to endosome swelling (24), whereas K+ exit accompanying H+ influx would produce endosome shrinkage, regulation of endosomal Cl or K+ conductances is predicted to alter endosome volume. Based on conclusions from our recent study on the role of endosomal Cl accumulation and swelling on transgene delivery (25), the ability of overexpression of a ClC-type Cl channel to enhance acidification and Cl entry provides a potential new tool to enhance gene delivery by non-viral mechanisms.
In summary, measurements of endosomal pH and [Cl] provide direct evidence for the involvement of a ClC-type Cl channel in endosomal acidification. The approach used here should be applicable to investigation of the role of other putative intracellular Cl channels, such as ClC-4, ClC-6, ClC-7, and AQP6, in organellar acidification. When available, specific high affinity inhibitors of ClC-type Cl channels will be useful to resolve the contributions of individual Cl channels because quantitative conclusions cannot be rigorously made using cells from knock-out mice or transfected systems.
| FOOTNOTES |
|---|
¶ To whom correspondence should be addressed: Cardiovascular Research Institute, 1246 Health Sciences East Tower, Box 0521, University of California, San Francisco, CA 94143-0521. Tel.: 415-476-8530; Fax: 415-665-3847; E-mail: verkman{at}itsa.ucsf.edu.
1 The abbreviations used are: CHO, Chinese hamster ovary;
2M,
2-macroglobulin; BAC, 10,10'-bis[3-carboxypropyl]-9,9'-biacridinium dinitrate; TMR, 5-(and 6)-carboxytetramethylrhodamine; Tf, transferrin; BAC-dextran-Tf-TMR, tetramethylrhodamine-labeled Tf conjugated to BAC-labeled dextran; BAC-dextran-
2M-TMR, tetramethylrhodamine-labeled
2M conjugated to BAC-labeled dextran; CF, 6-carboxyfluorescein; [Cl], Cl concentration; CTb, cholera toxin B-subunit; FITC, fluorescein isothiocyanate; FITC-Tf-TMR, Tf labeled with fluorescein and TMR; FITC-
2M-TMR,
2M labeled with fluorescein and TMR; PBS, phosphate-buffered saline. ![]()
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Okamoto, H. Kajiya, K. Toh, S. Uchida, M. Yoshikawa, S. Sasaki, M. A. Kido, T. Tanaka, and K. Okabe Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts Am J Physiol Cell Physiol, March 1, 2008; 294(3): C693 - C701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Reinehr, A. Sommerfeld, V. Keitel, S. Grether-Beck, and D. Haussinger Amplification of CD95 Activation by Caspase 8-induced Endosomal Acidification in Rat Hepatocytes J. Biol. Chem., January 25, 2008; 283(4): 2211 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Matsuda, M. S. Filali, K. A. Volk, M. M. Collins, J. G. Moreland, and F. S. Lamb Overexpression of CLC-3 in HEK293T cells yields novel currents that are pH dependent Am J Physiol Cell Physiol, January 1, 2008; 294(1): C251 - C262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Haggie and A. S. Verkman Cystic Fibrosis Transmembrane Conductance Regulator-independent Phagosomal Acidification in Macrophages J. Biol. Chem., October 26, 2007; 282(43): 31422 - 31428. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhao, X. Li, J. Hao, J. H. Winston, and S. A. Weinman The ClC-3 Chloride Transport Protein Traffics through the Plasma Membrane via Interaction of an N-terminal Dileucine Cluster with Clathrin J. Biol. Chem., September 28, 2007; 282(39): 29022 - 29031. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lassegue How Does the Chloride/Proton Antiporter ClC-3 Control NADPH Oxidase? Circ. Res., September 28, 2007; 101(7): 648 - 650. [Full Text] [PDF] |
||||
![]() |
F. J. Miller Jr, M. Filali, G. J. Huss, B. Stanic, A. Chamseddine, T. J. Barna, and F. S. Lamb Cytokine Activation of Nuclear Factor {kappa}B in Vascular Smooth Muscle Cells Requires Signaling Endosomes Containing Nox1 and ClC-3 Circ. Res., September 28, 2007; 101(7): 663 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Huynh and S. Grinstein Regulation of Vacuolar pH and Its Modulation by Some Microbial Species Microbiol. Mol. Biol. Rev., September 1, 2007; 71(3): 452 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Nascimento, M. A. F. Hayashi, A. Kerkis, V. Oliveira, E. B. Oliveira, G. Radis-Baptista, H. B. Nader, T. Yamane, I. L. dos Santos Tersariol, and I. Kerkis Crotamine Mediates Gene Delivery into Cells through the Binding to Heparan Sulfate Proteoglycans J. Biol. Chem., July 20, 2007; 282(29): 21349 - 21360. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Weylandt, M. Nebrig, N. Jansen-Rosseck, J. S. Amey, D. Carmena, B. Wiedenmann, C. F. Higgins, and A. Sardini ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment Mol. Cancer Ther., March 1, 2007; 6(3): 979 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Jentsch Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters J. Physiol., February 1, 2007; 578(3): 633 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poet, U. Kornak, M. Schweizer, A. A. Zdebik, O. Scheel, S. Hoelter, W. Wurst, A. Schmitt, J. C. Fuhrmann, R. Planells-Cases, et al. Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6 PNAS, September 12, 2006; 103(37): 13854 - 13859. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Reinehr, S. Becker, J. Braun, A. Eberle, S. Grether-Beck, and D. Haussinger Endosomal Acidification and Activation of NADPH Oxidase Isoforms Are Upstream Events in Hyperosmolarity-induced Hepatocyte Apoptosis J. Biol. Chem., August 11, 2006; 281(32): 23150 - 23166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morishita, T. Matsuzaki, M. Hara-chikuma, A. Andoo, M. Shimono, A. Matsuki, K. Kobayashi, M. Ikeda, T. Yamamoto, A. Verkman, et al. Disruption of Aquaporin-11 Produces Polycystic Kidneys following Vacuolization of the Proximal Tubule Mol. Cell. Biol., September 1, 2005; 25(17): 7770 - 7779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lambert and J. Oberwinkler Characterization of a proton-activated, outwardly rectifying anion channel J. Physiol., August 15, 2005; 567(1): 191 - 213. [Abstract] [Full Text] [PDF] |
||||
| < |